Article 29 May 2024 The Rescheduling Of Cannabis: What It Means, Next Steps, And Implications For Industry United States Cannabis
Article 17 Apr 2024 White House, Congress, And Federal Agencies Move To Limit Foreign Adversaries' Access To Sensitive Personal And Government Data Worldwide Privacy
Article 24 May 2023 What The Modernization Of Cosmetics Regulation Act Means For Hemp And CBD Cosmetic Manufacturers United States Cannabis
Article 15 Mar 2023 Senate Judiciary Committee Targeting Alleged "Anticompetitive" Biopharmaceutical Industry Practices United States Healthcare
Article 13 Feb 2023 FDA Announces A Path Forward For CBD Consumer Products: A New Regulatory Framework Is Needed United States Cannabis
Article 17 Oct 2022 Key Considerations For Evaluating FDA's Proposed Rule Redefining "Healthy" In The US And The EU Worldwide Healthcare
Article 27 Dec 2021 Research Roundup: FDA Uses Fall And Winter 2021 To Release Significant New Guidance Governing Hot-Button Life Sciences Research Topics United States Healthcare
Article 02 Nov 2021 FDA Guidance On Clinical Investigators Signing Form FDA 1572 And Practical Challenges Outside The US United States Healthcare
Article 30 Oct 2021 Federal District Court Upholds FDA's GRAS Self-Determination Process United States Healthcare
Article 14 Jul 2021 Addressing Emerging Issues In Online Selling: A Discussion Of Best Practices United States Consumer